96 related articles for article (PubMed ID: 24474454)
1. CD24 gene polymorphism--a novel prognostic factor in esophageal cancer.
Sadot E; Kraus S; Stein M; Naboishchikov I; Toledano O; Kazanov D; Arber N; Kashtan H
Int J Biol Markers; 2014 Mar; 29(1):e49-54. PubMed ID: 24474454
[TBL] [Abstract][Full Text] [Related]
2. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
3. CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer.
Takashima K; Fujii S; Komatsuzaki R; Komatsu M; Takahashi M; Kojima T; Daiko H; Minashi K; Chiwaki F; Muto M; Sasaki H; Yano T
Int J Oncol; 2020 Mar; 56(3):835-847. PubMed ID: 32124945
[TBL] [Abstract][Full Text] [Related]
4. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
[TBL] [Abstract][Full Text] [Related]
7. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
8. CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma.
Motoyama S; Mori K; Kamei T; Miura M; Hinai Y; Sato Y; Yoshino K; Sasaki T; Miyata G; Seto Y; Ogawa J
Ann Surg Oncol; 2013 Jun; 20(6):1978-84. PubMed ID: 23212764
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of CD24 in nonmelanoma skin cancer.
Miller E; Shapira S; Gur E; Naumov I; Kazanov D; Leshem D; Barnea Y; Meshiach Y; Gat A; Sion D; Arber N; Kraus S
Int J Biol Markers; 2012 Dec; 27(4):e331-6. PubMed ID: 23250778
[TBL] [Abstract][Full Text] [Related]
11. CD24 polymorphisms in breast cancer: impact on prognosis and risk.
Buck K; Hug S; Seibold P; Ferschke I; Altevogt P; Sohn C; Schneeweiss A; Burwinkel B; Jäger D; Flesch-Janys D; Chang-Claude J; Marmé F
Breast Cancer Res Treat; 2013 Feb; 137(3):927-37. PubMed ID: 23314606
[TBL] [Abstract][Full Text] [Related]
12. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma].
Dong ZM; Cui YJ; Kuang G; Wang R; Yu FL; Zhang JH
Ai Zheng; 2005 Oct; 24(10):1225-9. PubMed ID: 16219137
[TBL] [Abstract][Full Text] [Related]
14. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
16. A Dinucleotide Deletion in the
Segev L; Naboishchikov I; Kazanov D; Bernstein E; Shaked M; Arber N; Shapira S
Am Surg; 2020 May; 86(5):480-485. PubMed ID: 32684047
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer.
Ghadban T; Schmidt-Yang M; Uzunoglu FG; Perez DR; El Gammal AT; Miro JT; Wellner U; Pantel K; Izbicki JR; Vashist YK
Cancer Genet; 2015 Dec; 208(12):595-601. PubMed ID: 26598072
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
20. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]